logo

For the Inventor, By the Inventor

Raichur, India

Vimal Kumar Shrawat

This inventor holds 7 USPTO granted patents and 3 published patent applications. Top assignee: Shilpa Medicare Limited. Active years: 2014-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vimal Kumar Shrawat. Retrieved from https://idiyas.com/inventor/vimal-kumar-shrawat

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 28.6

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Karnataka, IN (2014 - 2016)
  • Raichur, IN (2014 - 2017)

Company Filing History:

goldMedal7 out of 32 
 
Shilpa Medicare Limited
 patents

Years Active: 2014-2017

Loading Chart...
7 patents (USPTO):Explore Patents
1. 9732030 - Process for the preparation of fingolimod and its salts (2017-08-15),
2. 9593083 - Crystalline erlotinib hydrochloride process (2017-03-14),
3. 9403785 - Process for preparing amorphous cabazitaxel (2016-08-02),
4. 9266816 - Fingolimod polymorphs and their processes (2016-02-23),
5. 9217001 - Crystalline bortezomib process (2015-12-22),
6. 8895772 - Process for preparing bicalutamide (2014-11-25),
7. 8829210 - Process for preparing docetaxel and its hydrate (2014-09-09),

Title: Vimal Kumar Shrawat: Innovator in Pharmaceutical Chemistry

Introduction

Vimal Kumar Shrawat is a notable inventor based in Raichur, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for active pharmaceutical ingredients. With a total of 7 patents to his name, Shrawat's work is instrumental in advancing treatments for various medical conditions.

Latest Patents

One of his latest patents is titled "Process for the preparation of fingolimod and its salts." This invention provides a method for preparing Fingolimod hydrochloride, which may be useful as an active pharmaceutical ingredient in compositions aimed at treating autoimmune-related disorders, including multiple sclerosis. Another significant patent is the "Crystalline erlotinib hydrochloride process." This invention outlines a method for preparing Crystalline Erlotinib HCl, characterized by specific X-ray powder diffraction patterns and thermal properties, making it valuable for cancer treatment.

Career Highlights

Vimal Kumar Shrawat is currently associated with Shilpa Medicare Limited, a company known for its focus on pharmaceutical development and manufacturing. His work at Shilpa Medicare has allowed him to contribute to innovative solutions in the pharmaceutical industry.

Collaborations

Shrawat has collaborated with several professionals in his field, including Prashant Purohit and Vinod Kumar Singh. These collaborations have further enhanced his research and development efforts.

Conclusion

Vimal Kumar Shrawat's contributions to pharmaceutical chemistry through his patents and work at Shilpa Medicare Limited highlight his role as an innovator in the industry. His inventions are paving the way for advancements in treatments for serious medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…